Philip Morris CEO: We're pleased with FDA approval of Zyn
Jacek Olczak, Philip Morris International CEO, joins CNBC's 'Money Movers' to discuss the company's most recent earnings.
Philip Morris’s stock touches record high as outlook tops Wall Street estimates
Philip Morris International Inc.’s stock touched a record high on Thursday after the company issued a profit outlook that ...
How Zyn helped Philip Morris International make a comeback
Zyn has taken the U.S. by storm. The nicotine pouch brand's boom came at an opportune time for parent company Philip Morris ...
Philip Morris International Reports 2024 Fourth-Quarter & Full-Year Results
Philip Morris International Inc. (PMI) (NYSE: PM) today announces its 2024 fourth-quarter and full-year results.1 "2024 was a remarkable year ...
business-review.eu9d
Philip Morris International announces that the U.S. Food and Drug Administration have authorized the marketing of ZYN Nicotine Pouch Products
The U.S. Food and Drug Administration (FDA), the US governmental authority responsible for regulating foods and medical ...
Philip Morris Q4: Earnings Beat, Smoke-Free Sales Gain Ground & More
Philip Morris International Inc. (NYSE:PM) shares are trading higher on Thursday after fourth-quarter FY24 earnings result.
NBC New York8d
How Zyn helped Philip Morris International make a comeback
The FDA determined that "due to substantially ... Zyn is manufactured by Swedish Match, which Philip Morris International acquired in a $16 billion deal in 2022. That year, Zyn shipped 238 ...
Philip Morris International: Market Is Underestimating The Company's True Growth Prospects
Philip Morris' impressive Q3 results highlight robust performance in both core and reduced-risk products. Read why I remain ...